Medical approaches to primary hyperparathyroidism.

Abstract

Medical therapy is useful in cases of acute primary hyperparathyroidism, patients with recurrent disease, and parathyroid carcinoma. Among the therapeutic agents that have been employed, oral phosphate, bisphosphonates, and estrogens have been successful. The newly described calcimimetic agents directly block secretion of parathyroid hormone from the glands and offer an important new approach to medical therapy of primary hyperparathyroidism.

• Authors: G J Strewler
• Journal: Endocrinology and metabolism clinics of North America (Endocrinol Metab Clin North Am) Vol. 29 Issue 3 Pg. 523-39, vi (Sep 2000) ISSN: 0889-8529 [Print] United States
• PMID: 11033759 (Publication Type: Journal Article, Review)

Chemical References

• Diphosphonates
• Estrogens
• Phosphates
• Progestins
• Calcium

Topics

• Calcium (agonists, physiology)
• Diphosphonates (therapeutic use)
• Estrogens (therapeutic use)
• Female
• Humans
• Hyperparathyroidism (drug therapy)
• Male
• Molecular Mimicry
• Parathyroid Neoplasms (complications, drug therapy)
• Phosphates (therapeutic use)
• Progestins (therapeutic use)